Egis Pharmaceuticals

Egis Pharmaceuticals PLC, a significant entity in the global healthcare landscape, is headquartered in Budapest, Hungary. It is recognized as one of the leading pharmaceutical companies with a principal operational focus on Central and Eastern Europe. The company's strategic advantage lies in its complete integration across the pharmaceutical value chain. This includes extensive research and development (R&D) initiatives, the meticulous production of Active Pharmaceutical Ingredients (APIs) and Finished Products (FPs), and comprehensive sales and marketing operations designed for broad market penetration.

The company's product catalog features a wide array of pharmaceutical offerings, from oral solid dosage forms like tablets to injectable solutions and complex galenic products. These high-quality medications are distributed to numerous countries globally, demonstrating Egis Pharmaceuticals' international reach. With a substantial employee base ranging from 1,000-5,000 employees and operating across 2 distinct locations, the company maintains a significant operational footprint. Its core business revolves around the development and distribution of generic pharmaceuticals, aiming to enhance accessibility to essential medicines.

Egis Pharmaceuticals operates firmly within the Pharmaceuticals and Healthcare sectors, specializing in generic pharmaceutical products. Its commitment to scientific advancement and market responsiveness is evident in its end-to-end value chain management. The company's success is driven by its dedicated workforce and strategic vision. For deeper insights into the leadership and personnel driving these advancements, one can Meet Egis Pharmaceuticals's team. The company's revenue stands at $100.0M, reflecting its strong market performance.